Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).
Aziz Nazha
Advertisement
Articles by Aziz Nazha
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).
Advertisement
Latest Updated Articles
Aziz Nazha Discusses the Future of Treating Patients With MDSPublished: October 1st 2015 | Updated:
Aziz Nazha on Adverse Events Associated With Treatment for MDSPublished: October 1st 2015 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Pancreatic Cancer on the Rise Among Younger Adults
2
Why ‘There is Hope’ For Patients With Pancreatic Cancer
3
FDA Approves Stoboclo and Osenvelt as Biosimilars for Some Cancers
4
Covering Every FDA Oncology Approval From October 2025
5
